For example, the null causal effect of CRP on coronary artery disease risk estimated using genetic variants having modest associations with CRP levels [26] suggests that the development of pharmacological agents to suppress usual CRP concentrations is not likely to be effective in reducing coronary heart disease incidence. The gene discussed is CRP; the disease is coronary artery disorder.